News
Weighing risks of pig transplants | W A B R E
www.wabre.org
transplantation,” said Sergio Traversa, a securities analyst with Mehta Partners, ...
Drug mergers: Courting trouble - The Economist
www.economist.com
According to Sergio Traversa, of Mehta Partners, a consultancy, the firms' products complement each other in lucrative franchises such as central ...
ICN Stock Loses More Ground - LA Times
www.latimes.com
"When you deal with risky areas like emerging markets, you sometimes face this kind of situation," said Sergio Traversa, an analyst with Mehta ...
Monsanto Ends Research on 2 Drugs - AP News
apnews.com
... the potential to garner a combined $500 million in annual sales, making them significant sellers but not blockbusters, said Sergio Traversa, ...
sorted by relevance / date